Now, a breakthrough that can help patients get the optimal benefit from their mental health meds.
87% OF PATIENTS who used Genomind Professional PGx to help select their medication showed measurable improvement.1
Genomind Professional PGx is designed to help minimize the trial and error process of both finding an effective psychiatric medication for a patient, as well as finding the right dosage level.
Why you should believe in our results:
- The FDA now requires that labeling on over 200 medications should include pharmacogentic biomarker warning or precaution information due to the potential impact of certain concomitant medications on efficacy.
- Our Lab operates under the most stringent state and federal standards for accreditation.
- Genes analyzed have been shown to be associated with a wide range of psychotropic medications, and can help inform treatment plans.
Help change lives with Genomind Professional PGx
- Brennan FX et al. A Naturalistic Study of the Effectiviness of Pharmacogenetic Testing to Guide Treamtment in Psychiatric Patients with Mood and Anxiety Disorders. Primary Care Companion CNS Disorders. 2015;17(2).
Answers are just three easy steps away
Your doctor will guide you through the process of getting your Genomind Professional PGx results.
A simple, non-invasive cheek swab test that can be administered quickly and easily in your office.
A complimentary consultation with experts in the field of psychoparmacogenetics is available with each report.
The results report provides clear clinical implications, and may eliminate some of the trial and error during treatment planning.